News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
775,705 Results
Type
Article (61698)
Company Profile (382)
Press Release (713625)
Multimedia
Podcasts (100)
Webinars (13)
Section
Business (220392)
Career Advice (3341)
Deals (37776)
Drug Delivery (125)
Drug Development (87026)
Employer Resources (196)
FDA (17369)
Job Trends (16363)
News (373903)
Policy (36294)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (9)
2024 BioForest Standard (1)
2024 BioMidwest Digital (11)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (12)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (6)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (9)
2024 Pharm Country Digital (9)
2024 Pharm Country Standard (6)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2973)
Academic (2)
Accelerated approval (5)
Adcomms (28)
Allergies (90)
Alliances (54444)
ALS (98)
Alzheimer's disease (1487)
Antibody-drug conjugate (ADC) (148)
Approvals (17339)
Artificial intelligence (290)
Autoimmune disease (26)
Automation (16)
Bankruptcy (392)
Best Places to Work (12377)
BIOSECURE Act (20)
Biosimilars (117)
Biotechnology (268)
Bladder cancer (73)
Brain cancer (29)
Breast cancer (291)
Cancer (2307)
Cardiovascular disease (196)
Career advice (2826)
Career pathing (34)
CAR-T (167)
Cell therapy (453)
Cervical cancer (21)
Clinical research (70220)
Collaboration (888)
Compensation (530)
Complete response letters (27)
COVID-19 (2838)
CRISPR (45)
C-suite (254)
Cystic fibrosis (106)
Data (2150)
Decentralized trials (2)
Denatured (36)
Depression (51)
Diabetes (281)
Diagnostics (6852)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (47)
Drug discovery (132)
Drug pricing (122)
Drug shortages (31)
Duchenne muscular dystrophy (100)
Earnings (89927)
Editorial (43)
Employer branding (25)
Employer resources (166)
Events (122720)
Executive appointments (752)
FDA (18637)
Featured Employer (56)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (796)
Gene editing (114)
Generative AI (27)
Gene therapy (331)
GLP-1 (820)
Government (5009)
Grass and pollen (6)
Guidances (52)
Healthcare (20490)
Huntington's disease (25)
IgA nephropathy (28)
Immunology and inflammation (137)
Indications (29)
Infectious disease (2996)
Inflammatory bowel disease (147)
Inflation Reduction Act (11)
Influenza (54)
Intellectual property (97)
Interviews (644)
IPO (17214)
IRA (51)
Job creations (4443)
Job search strategy (2317)
Kidney cancer (11)
Labor market (41)
Layoffs (531)
Leadership (22)
Legal (8961)
Liver cancer (79)
Lung cancer (333)
Lymphoma (152)
Machine learning (6)
Management (65)
Manufacturing (326)
MASH (73)
Medical device (14345)
Medtech (14350)
Mergers & acquisitions (21092)
Metabolic disorders (745)
Multiple sclerosis (84)
NASH (23)
Neurodegenerative disease (106)
Neuropsychiatric disorders (33)
Neuroscience (2063)
NextGen: Class of 2025 (7373)
Non-profit (4977)
Northern California (2659)
Now hiring (40)
Obesity (402)
Opinion (269)
Ovarian cancer (76)
Pain (92)
Pancreatic cancer (84)
Parkinson's disease (158)
Partnered (21)
Patents (243)
Patient recruitment (109)
Peanut (51)
People (63017)
Pharmaceutical (81)
Pharmacy benefit managers (20)
Phase I (21848)
Phase II (30742)
Phase III (23004)
Pipeline (1180)
Policy (162)
Postmarket research (3023)
Preclinical (9560)
Press Release (72)
Prostate cancer (104)
Psychedelics (38)
Radiopharmaceuticals (268)
Rare diseases (412)
Real estate (6701)
Recruiting (75)
Regulatory (24561)
Reports (55)
Research institute (2616)
Resumes & cover letters (536)
Rett syndrome (4)
RNA editing (4)
RSV (48)
Schizophrenia (77)
Series A (140)
Series B (88)
Service/supplier (18)
Sickle cell disease (58)
Southern California (2297)
Special edition (17)
Spinal muscular atrophy (160)
Sponsored (32)
Startups (4041)
State (2)
Stomach cancer (16)
Supply chain (72)
Tariffs (38)
The Weekly (62)
United States (23580)
Vaccines (781)
Venture capitalists (44)
Weight loss (282)
Women's health (37)
Worklife (19)
Date
Last 7 days (681)
Last 30 days (2381)
Last 365 days (34596)
2025 (10498)
2024 (37270)
2023 (42181)
2022 (53440)
2021 (58136)
2020 (57030)
2019 (50501)
2018 (38332)
2017 (35454)
2016 (35636)
2015 (41768)
2014 (35759)
2013 (31297)
2012 (33430)
2011 (33932)
2010 (32581)
Location
Africa (1012)
Alabama (54)
Alaska (7)
Arizona (257)
Arkansas (14)
Asia (44334)
Australia (8034)
California (6136)
Canada (2004)
China (535)
Colorado (272)
Connecticut (286)
Delaware (148)
Europe (99599)
Florida (900)
Georgia (215)
Hawaii (1)
Idaho (62)
Illinois (583)
India (29)
Indiana (321)
Iowa (11)
Japan (162)
Kansas (107)
Kentucky (25)
Louisiana (12)
Maine (62)
Maryland (923)
Massachusetts (4658)
Michigan (240)
Minnesota (410)
Mississippi (2)
Missouri (91)
Montana (31)
Nebraska (25)
Nevada (62)
New Hampshire (69)
New Jersey (1750)
New Mexico (31)
New York (1750)
North Carolina (1057)
North Dakota (8)
Northern California (2659)
Ohio (206)
Oklahoma (15)
Oregon (39)
Pennsylvania (1372)
Puerto Rico (12)
Rhode Island (34)
South America (1399)
South Carolina (22)
South Dakota (1)
Southern California (2297)
Tennessee (104)
Texas (914)
Utah (186)
Virginia (150)
Washington D.C. (67)
Washington State (575)
West Virginia (3)
Wisconsin (64)
775,705 Results for "verisante technology inc formerly known as t ray science".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Verisante Technology, Inc. Announces Update to Proposed RTO with SunRegen Healthcare AG
November 1, 2024
·
11 min read
Press Releases
Verisante Technology, Inc. Announces Proposed RTO with SunRegen Healthcare AG
August 14, 2024
·
14 min read
Verisante Technology, Inc. Announces 2023 AGM Results
Verisante Technology, Inc. is pleased to announce that at the 2023 Annual General Meeting held on December 18, 2023, in Vancouver, British Columbia, the Company’s shareholders voted in favour of all items of business.
December 20, 2023
·
1 min read
Business
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma
Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more small and midsize life sciences businesses. Choose New Jersey, Grace Therapeutics and Onyx Equities executives discuss the state’s life sciences scene.
April 10, 2025
·
6 min read
·
Angela Gabriel
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Verisante Technology Inc. Announces Shares for Debt Agreements
Verisante Technology, Inc. is pleased to announce it has agreed to convert certain payables owed to Creditors into common shares in the capital of the Company.
September 7, 2023
·
2 min read
Verisante Technology, Inc. Announces Exchange Approval for Shares for Debt Transaction
Verisante Technology, Inc. previously announced on September 7, 2023, that it had agreed to convert certain payables owed to Creditors into common shares in the capital of the Company.
October 5, 2023
·
3 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Business
Houston’s Life Sciences Scene Continues Boosting Its Reputation
While Houston isn’t yet on the same level as major life sciences hubs, it has plenty to offer and room to grow, according to CNS Pharmaceuticals, RadioMedix and Greater Houston Partnership executives.
March 13, 2025
·
6 min read
·
Angela Gabriel
Press Releases
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
April 25, 2025
·
6 min read
1 of 77,571
Next
